$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 20...
$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 2020, continued to grow by 1.4 times in 2021, typical pandemic stock. In 2022, there was a significant decline of 37.6%. Operating profit also reached a peak of 0.68 billion in 2021, then dropped sharply by 73% in 2022. Net income saw a substantial decrease of 72% in 2022.
Revenue declined by 79% in Q1 2023, both operating profit and net income entered into a loss range. Currently, the market cap is 1.15 billion, lacking investment value.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more